Skip to content
TrialScanner

NCT01981720

Extension Study of PRX-102 for up to 60 Months

Phase 1/Phase 2CompletedPLXLead

Registry record

Lead sponsor
Protalix
Conditions
Fabry Disease
Primary completion
Aug 26, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01981720 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01981720: Extension Study of PRX-102... | TrialScanner